The Weekly Litigation News Digest is now live. Subscribe now

Cell Culture Methods - EP3717631

The patent EP3717631 was granted to UCB Biopharma on Aug 30, 2023. The application was originally filed on Nov 29, 2018 under application number EP18811257A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3717631

UCB BIOPHARMA
Application Number
EP18811257A
Filing Date
Nov 29, 2018
Status
Granted And Under Opposition
Jul 28, 2023
Publication Date
Aug 30, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

OETKEMay 29, 2024WALLINGER RICKER SCHLOTTER TOSTMANNADMISSIBLE
COHAUSZ & FLORACKApr 11, 2024COHAUSZ & FLORACKADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006148074
DESCRIPTIONUS2013281355
DESCRIPTIONUS8765413
DESCRIPTIONWO2013158275
DESCRIPTIONWO9808934
INTERNATIONAL-SEARCH-REPORTWO2008033517
INTERNATIONAL-SEARCH-REPORTWO2017186654
OPPOSITIONEP2500415
OPPOSITIONKR20050070512
OPPOSITIONUS2013281355
OPPOSITIONUS2017204362
OPPOSITIONUS4927762
OPPOSITIONWO2008033517
OPPOSITIONWO2013158275
OPPOSITIONWO2013171156
OPPOSITIONWO2019106091
OPPOSITIONWO9808934

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents